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Abstract
Background: Extramedullary plasmacytoma (EMP) is a rare plasma cell neoplasm of soft tissue
without bone marrow involvement or other systemic characteristics of multiple myeloma
Case presentation: A 42 year-old woman presented with intermittent dry cough of 10 months
duration. Her breathing sound was slightly coarse without rales or rhonchi on auscultation. CT
scan revealed a right anterior mediastinal shadow with multiple pulmonary nodular lesions. A
video-assisted thoracoscopic surgery (VATS) was performed. Histopathology showed it to be a
myeloma.
Conclusion: This is the first presentation of EMP with a mediastinal mass with multiple pulmonary
nodules.
Background
Extramedullary plasmacytoma (EMP) is a plasma cell neo-
plasm of soft tissue without bone marrow involvement or
other systemic characteristics of multiple myeloma [1-3].
It is rare and mainly involves the upper aero-digestive
tract. Herein we report an extremely unusual presentation
as a mediastinal mass and multiple pulmonary nodules,
but without bone marrow involvement or other character-
istics of multiple myeloma.
Case presentation
A 42 year-old woman presented with intermittent dry
cough of ten months duration. No fever, chest tightness,
bone pain, anorexia, dyspnea on exertion or body weight
loss was noted. She took some medicines at a local clinic
to control her cough. However, blood-tinged sputum
appeared one month prior to hospital admission. No
bone pain or lymphadenopathy was noted on examina-
tion. Her breathing was slightly coarse without rales or
rhonchi on auscultation. A chest X-ray (Figure 1) and
computed tomography (CT) (Figure 2A, B) revealed a
right anterior mediastinal shadow with multiple pulmo-
nary nodular lesions.
Tracing back her history, she was a non-smoker, without
occupational or environmental exposure to air pollutants
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clinical manifestations nor had any died of cancer before.
No related travel history was noted during this time.
After admission, a bronchoscopic examination revealed
no endobronchial lesion or abnormal secretions. A pul-
monary function test showed a mild restrictive ventilatory
defect. The whole body bone scan was negative for tumor
involvement. A CT-guided biopsy was recommended but
the patient refused to undergo this procedure. The hemo-
gram, leukocyte differentiation count, and coagulating
profile were all within normal ranges.
A biopsy through video-assisted thoracoscopic surgery
(VATS) was then indicated to confirm the diagnosis. A 3
cm working incision and a 1 cm scope port were designed
for performing this procedure. Removing a wedge of lung
tissues including the masses from two separate sites were
performed smoothly and the microscopic examination
showed a solid mass made up mostly of plasma cells (Fig-
ure 3). These tumor cells stained positively for kappa light
chains (Figure 4), but negatively for lambda chains.
After confirming the diagnosis, the patient received a
series of related evaluations such as serum calcium, urine
Bence-Jones protein and plasma electrophoresis for M
protein detection. However, all of the above examinations
were negative. The skull, spine and pelvis X-ray revealed
no osteolytic lesions. The bone marrow biopsy revealed
normal patterns of cell distribution.
She received adjuvant chemotherapy, as originally
planned, including mephalan and steroids, and her symp-
toms improved after two months of treatment.
Discussion
Plasma cell neoplasm can be classified into the following
types: multiple myeloma (bone marrow and other sys-
temic involvements), solitary myeloma (bone plasmacy-
Chest CT scanFigure 2
Chest CT scan. A. a right anterior mediastinal shadow. B. multiple pulmonary nodular lesions.
The chest X-ray revealed multiple pulmonary nodular lesionsFigure 1
The chest X-ray revealed multiple pulmonary nodular 
lesions.Page 2 of 4
(page number not for citation purposes)
World Journal of Surgical Oncology 2007, 5:123 http://www.wjso.com/content/5/1/123toma), extramedullary (soft tissue) plasmacytoma, and
plasmablastic sarcoma [4]. Extramedullary plasmacytoma
(EMP), which belongs to the category of non-Hodgkin's
lymphoma, is present in about 3% of all plasma cell neo-
plasms [4-7]. It is defined as a soft-tissue plasma cell
tumor occurring in the absence of systemic signs of multi-
ple myeloma, such as bone osteolytic lesions, plasma cell
infiltration in bone marrow, lytic bone lesion, or serum or
urine myeloma protein (M-component) [1]. EMP affects
males three to four times more often than females, with
an average age of 55. However, one third of patients with
EMP are under 50 years old [1,6,8]. In a comprehensive
literature search reviewing over 700 patients with EMPs,
the EMPs were located predominantly (over 80%) at the
upper aeordigestive tract. Pulmonary or pleural EMPs,
which was first reported by Gordon and Walker [9], only
occurred in twelve of them [2]. Their presentations varied,
from a single pulmonary nodule (most commonly in the
hilum, the upper lobe of the lung, and both sides of the
lungs equally affected), a lobar or segmental consolida-
tion, to bilateral diffuse infiltrates [2,10-14]. However,
none of them had clinical pictures or image findings sim-
ilar to our presented case (a mediastinal mass with bilat-
eral multiple pulmonary nodules).
Diagnosis of undetermined pulmonary nodular lesions
can be accomplished by transbronchial, CT- or sono-
guide needle biopsy, as well as surgical biopsy through the
VATS or open thoracotomy [15,16]. VATS has been
increasingly applied for the diagnosis or treatment of
undetermined solitary or multiple pulmonary nodule(s)
because it is more accurate in diagnosis than needle
biopsy and less invasive in treatment than the open pro-
cedure [17].
The EMP should be differentiated from other plasma cell
tumors. As described in the above paragraph, there should
be no systemic signs to exclude the possibility of multiple
myeloma. In addition, the EMP should also be differenti-
ated from other types of plasma cell tumor, such as reac-
tive plasmacytoma and plasma cell granuloma, or
lymphoma (MALT, marginal and immunoblastic) [7,18].
Although the absence of M-spike on plasma electrophresis
cannot differentiate EMP from benign granuloma, [14],
the clinical characteristics such as the size of the main
mass and the numerous pulmonary seeding nodular
lesions favor the diagnosis of malignant EMP. The best
method to differentiate EMP from other types of plasma
cell tumors or lymphomas is that the EMP is positive for
CD38 and monoclonal cytoplasmic light chain expres-
sion of malignant plasma cells obtained by surgical or
needle biopsy.
Like other plasma cell tumors, EMPs are highly radiosen-
sitive with 80 to 100% of patients successfully achieving
local control and with a 50 to 65% ten-year disease-free
survival rate [19,20]. Surgery can be considered for local-
ized EMPs located in areas other than the head and neck,
such as the gastrointestinal tract [2]. Localized EMPs can
These tumor cells stained positively for kappa light chains (400×)Figure 4
These tumor cells stained positively for kappa light chains 
(400×).
Microscopically, abnormal plasma cells infiltrate in the lung parenchyma (A) nd abnorm l pl sma cells accompanied with amyl id (B) (H & E, 400×)Figure 3
Microscopically, abnormal plasma cells infiltrate in the lung 
parenchyma (A) and abnormal plasma cells accompanied with 
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also be effectively controlled by irradiation [21]. Multiple
disseminated pulmonary plasmacytoma, such as in our
presented patient, can be effectively controlled by differ-
ent regimens of combined chemotherapeutic agents, such
as mephalan and steroids, VMCP or VAMP, as described
in other literature [22-24]. The prognosis of patients with
EMP is usually better than those with multiple myeloma.
The EMPs, unlike solitary myeloma, advances to multiple
myeloma only in a minority of cases [12]. The local recur-
rence rate is about 10–30%, with a 17–48% progression
to multiple myeloma and the median survival of about
63–101 months [24].
Conclusion
We presented a case of EMP with a mediastinal mass with
multiple pulmonary nodules. After reviewing the litera-
ture, this has never before been reported as a clinical man-
ifestation of EMP.
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